85 related articles for article (PubMed ID: 3106279)
21. Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24.
Veronese FD; Copeland TD; Oroszlan S; Gallo RC; Sarngadharan MG
J Virol; 1988 Mar; 62(3):795-801. PubMed ID: 3123712
[TBL] [Abstract][Full Text] [Related]
22. Conserved immunogenic region of a major core protein (p24) of human and simian immunodeficiency viruses.
Koito A; Hattori T; Matsushita S; Maeda Y; Nozaki C; Sagawa K; Takatsuki K
AIDS Res Hum Retroviruses; 1988 Dec; 4(6):409-17. PubMed ID: 2464360
[TBL] [Abstract][Full Text] [Related]
23. Major core proteins, p24s, of human, simian, and feline immunodeficiency viruses are partly expressed on the surface of the virus-infected cells.
Nishino Y; Ohki K; Kimura T; Morikawa S; Mikami T; Ikuta K
Vaccine; 1992; 10(10):677-83. PubMed ID: 1326145
[TBL] [Abstract][Full Text] [Related]
24. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein.
Moradpour D; Wakita T; Tokushige K; Carlson RI; Krawczynski K; Wands JR
J Med Virol; 1996 Mar; 48(3):234-41. PubMed ID: 8801283
[TBL] [Abstract][Full Text] [Related]
25. Development and characterization of monoclonal antibodies to spring viraemia of carp virus.
Chen ZY; Liu H; Li ZQ; Zhang QY
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):266-76. PubMed ID: 18378003
[TBL] [Abstract][Full Text] [Related]
26. Location of epitopes on the major core protein p24 of human immunodeficiency virus.
Langedijk JP; Schalken JJ; Tersmette M; Huisman JG; Meloen RH
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2609-14. PubMed ID: 1701476
[TBL] [Abstract][Full Text] [Related]
27. An anti-p24 monoclonal antibody shows cross-reactivity with multiple HIV-1 proteins.
Liang CM; Henry S; Liang SM; Epstein JS
J Immunol Methods; 1990 Aug; 132(1):57-62. PubMed ID: 2118162
[TBL] [Abstract][Full Text] [Related]
28. Identification of gag precursor of equine infectious anaemia virus with monoclonal antibodies to the major viral core protein, p26.
Hussain KA; Issel CJ; Rwambo PM; Arnizaut AB; Ball JM; Schnorr KL; Montelaro RC
J Gen Virol; 1988 Jul; 69 ( Pt 7)():1719-24. PubMed ID: 2839604
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of infected cell appearance as a determinant of number of human immunodeficiency virus-1 infectious units.
Cory JM; Ohlsson-Wilhelm BM; Steck ME; Smithgall MD; Rozday V; Eyster ME; Rapp F
AIDS Res Hum Retroviruses; 1989 Feb; 5(1):97-106. PubMed ID: 2497763
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies to type D retrovirus (SRV-2).
Tsai CC; Tsai CC; Sligh JM; Yarnall M; Follis KE; Roodman ST
J Med Primatol; 1989; 18(3-4):175-83. PubMed ID: 2547955
[TBL] [Abstract][Full Text] [Related]
31. Liquid competition radioimmunoassay for the detection and quantitation of the HIV p24.
Caruso A; Terlenghi L; Ceccarelli R; Verardi R; Foresti I; Scura G; Manca N; Bonfanti C; Turano A
J Virol Methods; 1987 Sep; 17(3-4):199-210. PubMed ID: 2445771
[TBL] [Abstract][Full Text] [Related]
32. Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation.
Ferns RB; Tedder RS; Weiss RA
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1543-51. PubMed ID: 2438375
[TBL] [Abstract][Full Text] [Related]
33. Hormone reduces levels of AIDS virus in blood.
Oncology (Williston Park); 1989 Oct; 3(10):19. PubMed ID: 2518005
[No Abstract] [Full Text] [Related]
34. Identification of protein intermediates in the processing of the p55 HIV-1 gag precursor in cells infected with recombinant vaccinia virus.
Gowda SD; Stein BS; Engleman EG
J Biol Chem; 1989 May; 264(15):8459-62. PubMed ID: 2785991
[TBL] [Abstract][Full Text] [Related]
35. Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag.
Tersmette M; Winkel IN; Groenink M; Gruters RA; Spence RP; Saman E; Van Der Groen G; Miedema F; Huisman JG
Virology; 1989 Jul; 171(1):149-55. PubMed ID: 2472701
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne).
Henderson LE; Benveniste RE; Sowder R; Copeland TD; Schultz AM; Oroszlan S
J Virol; 1988 Aug; 62(8):2587-95. PubMed ID: 3292789
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of human immunodeficiency virus (HIV) core precursor (p55) expressed in Saccharomyces cerevisiae.
Vlasuk GP; Waxman L; Davis LJ; Dixon RA; Schultz LD; Hofmann KJ; Tung JS; Schulman CA; Ellis RW; Bencen GH
J Biol Chem; 1989 Jul; 264(20):12106-12. PubMed ID: 2663848
[TBL] [Abstract][Full Text] [Related]
38. Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens.
Ikuta K; Morita C; Miyake S; Ito T; Okabayashi M; Sano K; Nakai M; Hirai K; Kato S
Virology; 1989 Jun; 170(2):408-17. PubMed ID: 2499113
[TBL] [Abstract][Full Text] [Related]
39. Virus-specific polypeptides of caprine arthritis-encephalitis virus recognized by monoclonal antibodies to virion proteins p24 and p14.
Belov L; Whalley JM
J Gen Virol; 1988 May; 69 ( Pt 5)():1097-103. PubMed ID: 3373182
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of HIV-1 infection in vitro by murine monoclonal anti-p24 antibodies.
Franke L; Grunow R; Meissner K; Porstmann T; von Baehr R
J Med Virol; 1992 Jun; 37(2):137-42. PubMed ID: 1629712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
